Inventor
SENTER PETER D
US36 patents
⚠️ This page may combine multiple inventors who share the name “SENTER PETER D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEATTLE GENETICS INC
17 patentsUS7851437B2Dec 14, 2010
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
SEATTLE GENETICS INC163 citations99
US7829531B2Nov 9, 2010
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
SEATTLE GENETICS INC199 citations99
US7659241B2Feb 9, 2010
Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
SEATTLE GENETICS INC442 citations99
US7553816B2Jun 30, 2009
p-amidobenzylethers in drug delivery agents
SEATTLE GENETICS INC178 citations99
US7498298B2Mar 3, 2009
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC1,111 citations99
US7091186B2Aug 15, 2006
p-Amidobenzylethers in drug delivery agents
SEATTLE GENETICS INC211 citations99
US7994135B2Aug 9, 2011
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC164 citations98
US7964566B2Jun 21, 2011
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC209 citations98
US7964567B2Jun 21, 2011
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC134 citations98
US7745394B2Jun 29, 2010
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC193 citations98
US6884869B2Apr 26, 2005
Pentapeptide compounds and uses related thereto
SEATTLE GENETICS INC562 citations98
US7256257B2Aug 14, 2007
Pentapeptide compounds and uses related thereto
SEATTLE GENETICS INC69 citations97
US7098308B2Aug 29, 2006
Pentapeptide compounds and uses related thereto
SEATTLE GENETICS INC101 citations97
US7423116B2Sep 9, 2008
Pentapeptide compounds and uses related thereto
SEATTLE GENETICS INC51 citations96
US10808039B2Oct 20, 2020
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC18 citations94
US10414826B2Sep 17, 2019
Monomethylvaline compounds capable of conjugation to ligands
SEATTLE GENETICS INC8 citations84
US9522194B2Dec 20, 2016
Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus
SEATTLE GENETICS INC1 citations51
DANA FARBER CANCER INST INC
5 patentsUS4625014ANov 25, 1986
Cell-delivery agent
DANA FARBER CANCER INST INC255 citations99
US4569789AFeb 11, 1986
Acid-cleavable compound, use in protein conjugates and drug delivery systems
DANA FARBER CANCER INST INC458 citations99
US4542225ASep 17, 1985
Acid-cleavable compound
DANA FARBER CANCER INST INC107 citations97
US4618492AOct 21, 1986
Acid-cleavable compound
DANA FARBER CANCER INST INC98 citations96
US4888415ADec 19, 1989
Gelonin immunotoxin
DANA FARBER CANCER INST INC49 citations92
BRISTOL MYERS CO
5 patentsUS4975278ADec 4, 1990
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
BRISTOL MYERS CO1,011 citations98
US4952394AAug 28, 1990
Drug-monoclonal antibody conjugates
BRISTOL MYERS CO134 citations98
US5041424AAug 20, 1991
Epipodophyllotoxin glucoside 4'-phosphate derivatives
BRISTOL MYERS CO68 citations96
US4904768AFeb 27, 1990
Epipodophyllotoxin glucoside 4'-phosphate derivatives
BRISTOL MYERS CO37 citations92
US4874779AOct 17, 1989
Mitomycin phosphate derivatives
BRISTOL MYERS CO10 citations74
DORONINA SVETLANA O
3 patentsUS8703714B2Apr 22, 2014
Monomethylvaline compounds capable of conjugation to ligands
DORONINA SVETLANA O59 citations97
US8557780B2Oct 15, 2013
Monomethylvaline compounds capable of conjugation to ligands
DORONINA SVETLANA O32 citations96
US8871720B2Oct 28, 2014
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
DORONINA SVETLANA O29 citations91
BRISTOL MYERS SQUIBB CO
3 patentsUS5773435AJun 30, 1998
Prodrugs for β-lactamase and uses thereof
BRISTOL MYERS SQUIBB CO71 citations93
USRE35524EJun 3, 1997
Epipodophyllotoxin glucoside 4'-phosphate derivatives
BRISTOL MYERS SQUIBB CO27 citations92
US6132722AOct 17, 2000
Recombinant antibody-enzyme fusion proteins
BRISTOL MYERS SQUIBB CO52 citations91